Navigation Links
Complete Agenda Announced for 11th Annual Patient Adherence Forum
Date:1/11/2012

BOSTON, Jan. 11, 2012 /PRNewswire/ -- CBI, a division of Advanstar Communications, is pleased to announce the agenda for the 11th Annual Patient Adherence Forum, which is being held April 26 - 27, 2012 at the Loews Hotel in Philadelphia, PA. At the event, industry experts share their strategies for improving patient outcomes and product utilization through stakeholder collaboration and patient engagement. 

Conference highlights include:

  • The 7th Annual Strategic Patient Adherence (SPA) Awards, co-sponsored by CBI and Pharmaceutical Executive. The awards are presented during the conference and give well-deserved recognition for the hard work and dedication of the nominees to improving adherence. Nominations are accepted thru February 3rd. Visit http://www.cbinet.com/spaawards for more information or to apply.
  • A Keynote Presentation from CMS on understanding healthcare reform's greatest impacts on moving the adherence needle.
  • A Keynote Presentation from Weight Watchers for a cross-industry approach to sustainably addressing unhealthy behavior.
  • A Featured Session from D. Stuart Sowder of Pfizer Inc (a 2011 Pharmaceutical Executive Emerging Leader) on utilizing innovative medical communications to educate and motivate patient behavior.

Join us in April for what promises to be a thought-provoking and educational opportunity. To view the entire agenda visit http://www.cbinet.com/patientadherence. For more information call 800-817-8601. If you would like to apply for a press pass contact Lauren Donoghue: lauren.donoghue@cbinet.com.   

Sponsors and Exhibitors include 5th Finger, Adheris, Lash Group and FICO. For more information on sponsorship opportunities contact Lauren Moras: lauren.moras@cbinet.com

About CBI:

A subsidiary of Advanstar Communications, CBI offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy and decision makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit http://www.cbinet.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE CBI
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. goBalto Completes a Successful FDA 21 CFR Part 11 Compliance Audit
2. MiMedx Group Completes $5,000,000 Private Placement
3. Epitomics, Inc. and University of California, Davis, Complete Star Program for High-Throughput Measurement of Antibody-Antigen Interactions
4. PDL BioPharma Completes Regular Quarterly Dividend Payment
5. CeNeRx BioPharma Completes $4.85 Million Financing
6. Aratana Therapeutics Completes $15 Million Series B Financing
7. InnoPharma Completes $15 Million Series A Financing
8. Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising
9. Agendia Successfully Completes Bi-Annual FDA Inspection
10. Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment
11. HeartWare Completes GLP Studies of Next Generation MVAD® Pump; Data Presented Today at ISRBP Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 2016  In the pharmaceutical industry the medical affairs ... launch activities including the identification and engagement of key ... especially high in the oncology therapeutic area where most ... the Role of Medical Affairs in Oncology Launch Excellence ... therapies find better ways to utilize medical affairs to ...
(Date:2/5/2016)... -- Amarantus BioScience Holdings, Inc. ... products for Regenerative Medicine, Neurology and Orphan Diseases, announced ... from the US Food and Drug Administration (FDA) for ... granted orphan drug designation (ODD) by the US FDA ... Inc. (OTCQB: AMBS), a biotechnology company ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... compliance training, today announced an interactive FDA compliance training course, ... (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now conveniently available on ...
(Date:2/4/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the ... Edward Lanphier , Sangamo,s president and chief executive officer, ... ZFP Therapeutic ® development programs and an overview ... on Thursday, February 11, 2016, at the Leerink Partners ... is being held in New York ...
Breaking Biology Technology:
(Date:2/3/2016)... 2016 --> --> Fourth ... (105.0), up 1,187% compared with fourth quarter of 2014. Gross ... M (loss: 30.0). Earnings per share increased to SEK 6.39 ... M (neg: 74.7). , --> ... SEK 2,900.5 M (233.6), up 1,142% compared with 2014. Gross ...
(Date:2/3/2016)... , Feb. 3, 2016 ... the addition of the "Emotion Detection ... Machine Learning, and Others), Software Tools (Facial ... Areas, End Users,and Regions - Global forecast ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has ...
(Date:2/2/2016)... 2, 2016 Checkpoint Inhibitors for Cancer ... Are you interested in the future of ... checkpoint inhibitors. Visiongain,s report gives those predictions to ... national level. Avoid falling behind in data ... and revenues those emerging cancer therapies can achieve. ...
Breaking Biology News(10 mins):